PCV25 A Pharmacoeconomic Assessment of Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in a Tertiary Hospital in China
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.192
https://www.valueinhealthjournal.com/article/S1098-3015(12)01905-5/fulltext
Section Title :
Cardiovascular Disorders
Section Order :
1734
First Page :
A632
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01905-5&doi=10.1016/j.jval.2012.08.192